5岁以下儿童的亚托皮肤炎:中欧,东欧和西欧的流行趋势
Irena Ilic1, Andjelka Stojkovic2,3, Vesna Velickovic3
1Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
亚托邦性皮肤炎仍然是欧洲5岁以下儿童的重大健康问题. 流行趋势因地区而异,在过去三十年中,东欧的发病率上升,西欧和中欧的发病率略有下降.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 儿科 儿科 儿科
背景情况:
- 亚托邦性皮肤炎 (AD) 是一个全球公共卫生问题,在欧洲关于儿科患病率趋势的数据很少.
- 了解这些趋势对于有针对性的公共卫生干预至关重要.
研究的目的:
- 评估5岁以下儿童中亚型皮肤炎的流行趋势.
- 分析1990年至2019年中欧,东欧和西欧各次区域的趋势.
主要方法:
- 描述性,观察性流行病学研究.
- 生态研究设计.
- 用于趋势评估的joinpoint回归分析.
主要成果:
- 在欧洲5岁以下的儿童中,有1.18亿个患有亚托邦性皮肤炎的流行病例 (1990-2019).
- 在东欧 (爱沙尼亚,俄罗斯联邦) 观察到的患病率最高,在罗马尼亚和拉脱维亚最低.
- 东欧的流行趋势增加 (+0.3%男性/年, +0.1%女性/年);西欧/中欧略有下降 (-0.1%/年).
- 注意到性别差异;与人类发展指数的相关性因地区而异.
结论:
- 亚托邦性皮肤炎仍然是欧洲幼儿的主要健康问题,原因是其患病率很高,并且在过去三十年中趋势稳定.
- 患病率和趋势的区域差异凸显了对地理位置量身定制的公共卫生战略的需求.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
相关概念视频
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
